The effects of hydroxyethyl starch on blood coagulation were investigated i
n 20 patients undergoing surgery to determine whether its use places recipi
ents at risk of haemorrhage or thrombosis. The partial thromboplastin times
are significantly prolonged; factor VIII activities and fibrinogen levels
are decreased. After infusion of hydroxyethyl starch, no significant differ
ences were detected in platelet count or prothrombin time. A decreased plat
elet aggregation was also found after the infusion of hydroxyethyl starch.
According to our results, hydroxyethyl starch can cause haemorrhagic proble
ms in patients when administered as a colloidal volume-expanding agent.